Publications by authors named "Daniel Rea"

Claim this Profile
D
Does RSClin provide additional information over classic clinico-pathologic scores (PREDICT 2.1, INFLUENCE 2.0, CTS5)?
Ana-Alicia Beltran-Bless, Gregory R Pond, Jane Bayani, Sarah L Barker, Melanie Spears, Daniel W Rea

Breast· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared with mRNA vaccines in haematopoietic cell transplant recipients.
Hayley Colton, Natalie Barratt, Nigel Temperton, Hailey Hornsby, Adrienn Angyal, Daniel Rea

Br J Haematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LD-transpeptidation is crucial for fitness and polar growth in Agrobacterium tumefaciens.
Alena Aliashkevich, Thomas Guest, Laura Alvarez, Michael C Gilmore, Daniel Rea

PLoS Genet· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial.
Carl S Goodyear, Amit Patel, Eleanor Barnes, Michelle Willicombe, Stefan Siebert, Daniel Rea

Lancet Rheumatol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the Prognostic Performance of Breast Cancer Index in Hormone Receptor-Positive Postmenopausal Breast Cancer Patients in the TEAM Trial.
John M S Bartlett, Keying Xu, Jenna Wong, Gregory Pond, Yi Zhang, Daniel Rea

Clin Cancer Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single drop cytometry onboard the International Space Station.
Daniel J Rea, Rachael S Miller, Brian E Crucian, Russell W Valentine, Samantha Cristoforetti

Nat Commun· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer.
Pamela J Goodwin, Bingshu E Chen, Karen A Gelmon, Timothy J Whelan, Marguerite Ennis, Daniel W Rea

J Clin Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
It's not what you think: shaping beliefs about a robot to influence a teleoperator's expectations and behavior.
Daniel J Rea, James E Young

Front Robot AI· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recruiting women with ductal carcinoma in situ to a randomised controlled trial: lessons from the LORIS study.
Sally Wheelwright, Lucy Matthews, Valerie Jenkins, Shirley May, Daniel Rea

Trials· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease.
Eleanor Barnes, Carl S Goodyear, Michelle Willicombe, Charlotte Gaskell, Stefan Siebert, Daniel Rea

Nat Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hey Robot, Tell It to Me Straight: How Different Service Strategies Affect Human and Robot Service Outcomes.
Masaharu Naito, Daniel J Rea, Takayuki Kanda

Int J Soc Robot· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the Immune Microenvironment in Inflammatory Breast Cancer Using Multiplex Immunofluorescence.
Nahla M Badr, Jack L McMurray, Irini Danial, Steven Hayward, Nancy Y Asaad, Daniel Rea, Andrea Stevens

Pathobiology· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eribulin Treatment for Patients with Metastatic Breast Cancer: The UK Experience - A Multicenter Retrospective Study.
Mariam Jafri, Hartmut Kristeleit, Vivek Misra, Mark Baxter, Samreen Ahmed, Daniel Rea

Oncology· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER+ Invasive Breast Cancer (STAKT).
John F R Robertson, Robert E Coleman, Kwok-Leung Cheung, Abigail Evans, Chris Holcombe, Daniel Rea

Clin Cancer Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlative studies of the Breast Cancer Index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine therapy benefit: a Trans-aTTom study.
Dennis C Sgroi, Kai Treuner, Yi Zhang, Tammy Piper, Ranelle Salunga, Daniel Rea

Breast Cancer Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discordance between Immunohistochemistry and Erb-B2 Receptor Tyrosine Kinase 2 mRNA to Determine Human Epidermal Growth Factor Receptor 2 Low Status for Breast Cancer.
Keying Xu, Jane Bayani, Elizabeth Mallon, Gregory R Pond, Tammy Piper, Daniel W Rea

J Mol Diagn· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast Cancer Index Is a Predictive Biomarker of Treatment Benefit and Outcome from Extended Tamoxifen Therapy: Final Analysis of the Trans-aTTom Study.
John M S Bartlett, Dennis C Sgroi, Kai Treuner, Yi Zhang, Tammy Piper, Daniel W Rea

Clin Cancer Res· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial.
Pamela J Goodwin, Bingshu E Chen, Karen A Gelmon, Timothy J Whelan, Marguerite Ennis, Daniel W Rea

JAMA· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Still Not Solved: A Call for Renewed Focus on User-Centered Teleoperation Interfaces.
Daniel J Rea, Stela H Seo

Front Robot AI· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Antigen 15-3/Mucin 1 Levels in CCTG MA.32: A Breast Cancer Randomized Trial of Metformin vs Placebo.
Pamela J Goodwin, Ryan J O Dowling, Marguerite Ennis, Bingshu E Chen, Wendy R Parulekar, Daniel W Rea

JNCI Cancer Spectr· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study.
John M S Bartlett, Jane Bayani, Elizabeth Kornaga, Keying Xu, Greg R Pond, Daniel Rea

NPJ Breast Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial.
Pamela J Goodwin, Ryan J O Dowling, Marguerite Ennis, Bingshu E Chen, Wendy R Parulekar, Andrea Molckovsky, Daniel W Rea

NPJ Breast Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Metformin vs Placebo on Sex Hormones in Canadian Cancer Trials Group MA.32.
Isabel Pimentel, Bingshu E Chen, Ana Elisa Lohmann, Marguerite Ennis, Jennifer Ligibel, Daniel Rea

J Natl Cancer Inst· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial.
Nicholas C Turner, Belinda Kingston, Lucy S Kilburn, Sarah Kernaghan, Andrew M Wardley, Daniel Rea

Lancet Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT.
Helena Earl, Louise Hiller, Anne-Laure Vallier, Shrushma Loi, Karen McAdam, Daniel Rea

Health Technol Assess· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis